The baby formula manufacturer whose facility was shut down earlier this year has resumed production at the factory.
Abbott announced over the weekend that it restarted formula production at the Sturgis, Michigan, facility.
The resumption comes after Abbott met initial requirements outlined in a consent decree it recently reached with the U.S. Food and Drug Administration (FDA).
Abbott is focusing on producing specialty formulas like EleCare, which is designed for infants who cannot consume intact or hydrolyzed protein.
The first products being produced are expected to be available to consumers on or around June 20.
“We’re also working hard to fulfill the steps necessary to restart production of Similac and other formulas and will do so as soon as we can,” Abbott said in a statement….